Correlation Between ScinoPharm Taiwan and Maxigen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ScinoPharm Taiwan and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScinoPharm Taiwan and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScinoPharm Taiwan and Maxigen Biotech, you can compare the effects of market volatilities on ScinoPharm Taiwan and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScinoPharm Taiwan with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScinoPharm Taiwan and Maxigen Biotech.

Diversification Opportunities for ScinoPharm Taiwan and Maxigen Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ScinoPharm and Maxigen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ScinoPharm Taiwan and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and ScinoPharm Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScinoPharm Taiwan are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of ScinoPharm Taiwan i.e., ScinoPharm Taiwan and Maxigen Biotech go up and down completely randomly.

Pair Corralation between ScinoPharm Taiwan and Maxigen Biotech

Assuming the 90 days trading horizon ScinoPharm Taiwan is expected to generate 0.78 times more return on investment than Maxigen Biotech. However, ScinoPharm Taiwan is 1.29 times less risky than Maxigen Biotech. It trades about -0.02 of its potential returns per unit of risk. Maxigen Biotech is currently generating about -0.02 per unit of risk. If you would invest  2,690  in ScinoPharm Taiwan on September 2, 2024 and sell it today you would lose (350.00) from holding ScinoPharm Taiwan or give up 13.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ScinoPharm Taiwan  vs.  Maxigen Biotech

 Performance 
       Timeline  
ScinoPharm Taiwan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ScinoPharm Taiwan has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Maxigen Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maxigen Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Maxigen Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

ScinoPharm Taiwan and Maxigen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ScinoPharm Taiwan and Maxigen Biotech

The main advantage of trading using opposite ScinoPharm Taiwan and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScinoPharm Taiwan position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.
The idea behind ScinoPharm Taiwan and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets